Drug and Medication Analysis & Statistics in Slovenia, March 2015

24/7 Customer Support

Talk to Louis

+1 718 618 4302

All regions

data types

1-21 of 21 reports

Purchase Reports From Reputable Market Research Publishers

EU: Heterocyclic Compounds - Market Report. Analysis and Forecast to 2020

EU: Heterocyclic Compounds - Market Report. Analysis and Forecast to 2020

  • $ 2 161
  • Industry report
  • March 2015
  • by IndexBox Marketing

The report provides an in-depth analysis of the EU market for Heterocyclic Compounds. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics ...

  • Industries : Drug and Medication
  • Countries : Europe, Czech Republic, United Kingdom, Netherlands, Luxembourg, Lithuania, World, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Romania, Portugal, Poland, Malta, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Cyprus, Croatia, Bulgaria, Belgium, Austria
EU: Hormones, Prostaglandins, Thromboxanes And Leukotrienes - Market Report. Analysis and Forecast to 2020

EU: Hormones, Prostaglandins, Thromboxanes And Leukotrienes - Market Report. Analysis and Forecast to 2020

  • $ 2 161
  • Industry report
  • March 2015
  • by IndexBox Marketing

The report provides an in-depth analysis of the EU Market of Hormones, Prostaglandins, Thromboxanes And Leukotrienes. It presents the latest data of the market size and volume, domestic production, exports ...

  • Industries : Drug and Medication
  • Countries : Europe, Czech Republic, United Kingdom, Netherlands, Luxembourg, Lithuania, World, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Romania, Portugal, Poland, Malta, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Cyprus, Croatia, Bulgaria, Belgium, Austria
EU: Antibiotics - Market Report. Analysis and Forecast to 2020

EU: Antibiotics - Market Report. Analysis and Forecast to 2020

  • $ 2 161
  • Industry report
  • March 2015
  • by IndexBox Marketing

The report provides an in-depth analysis of the EU Market of Antibiotics. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnove ...

  • Industries : Drug and Medication
  • Countries : Europe, Czech Republic, United Kingdom, Netherlands, Luxembourg, Lithuania, World, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Romania, Portugal, Poland, Malta, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Cyprus, Croatia, Bulgaria, Belgium, Austria
EU: Vaccines For Human Medicine - Market Report. Analysis and Forecast to 2020

EU: Vaccines For Human Medicine - Market Report. Analysis and Forecast to 2020

  • $ 2 161
  • Industry report
  • March 2015
  • by IndexBox Marketing

The report provides an in-depth analysis of the EU Market of Vaccines For Human Medicine. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics ...

  • Industries : Drug and Medication
  • Countries : Europe, Czech Republic, United Kingdom, Netherlands, Luxembourg, Lithuania, World, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Romania, Portugal, Poland, Malta, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Cyprus, Croatia, Bulgaria, Belgium, Austria
EU: Lactams From Heterocyclic Compounds - Market Report. Analysis and Forecast to 2020

EU: Lactams From Heterocyclic Compounds - Market Report. Analysis and Forecast to 2020

  • $ 2 161
  • Industry report
  • March 2015
  • by IndexBox Marketing

The report provides an in-depth analysis of the EU market for Lactams From Heterocyclic Compounds. It presents the latest data of the market size and volume, domestic production, exports and imports, ...

  • Industries : Drug and Medication
  • Countries : Europe, Czech Republic, United Kingdom, Netherlands, Luxembourg, Lithuania, World, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Romania, Portugal, Poland, Malta, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Cyprus, Croatia, Bulgaria, Belgium, Austria
Slovenia: Antibiotics - Market Report. Analysis and Forecast to 2020

Slovenia: Antibiotics - Market Report. Analysis and Forecast to 2020

  • $ 2 161
  • Industry report
  • March 2015
  • by IndexBox Marketing

The report provides an in-depth analysis of the Market for Antibiotics in Slovenia. It presents the latest data of the market size and volume, European production, exports and imports, price dynamics ...

  • Industries : Drug and Medication
  • Countries : Slovenia
Slovenia: Heterocyclic Compounds - Market Report. Analysis and Forecast to 2020

Slovenia: Heterocyclic Compounds - Market Report. Analysis and Forecast to 2020

  • $ 2 161
  • Industry report
  • March 2015
  • by IndexBox Marketing

The report provides an in-depth analysis of the Market for Heterocyclic Compounds in Slovenia. It presents the latest data of the market size and volume, European production, exports and imports, price ...

  • Industries : Drug and Medication
  • Countries : Slovenia
Slovenia: Hormones, Prostaglandins, Thromboxanes And Leukotrienes - Market Report. Analysis and Forecast to 2020

Slovenia: Hormones, Prostaglandins, Thromboxanes And Leukotrienes - Market Report. Analysis and Forecast to 2020

  • $ 2 161
  • Industry report
  • March 2015
  • by IndexBox Marketing

The report provides an in-depth analysis of the Market for Hormones, Prostaglandins, Thromboxanes And Leukotrienes in Slovenia. It presents the latest data of the market size and volume, European production, ...

  • Industries : Drug and Medication
  • Countries : Slovenia
Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2015
  • by Business Monitor International

BMI View: Slovenia's pharmaceutical industry outlook remains broadly unchanged in our Q212 assessment. While weak economic data and revised projections have led us to adjust our drug industry projections ...

  • Industries : Drug and Medication
  • Countries : Slovenia
Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • November 2014
  • by Business Monitor International

BMI View: Although Slovenia is a small pharmaceutical industry, the country boasts a well-developed healthcare system and solid infrastructure, propped up by high per capita spending on healthcare. However, ...

  • Industries : Drug and Medication
  • Countries : Slovenia
Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • September 2014
  • by Business Monitor International

BMI View: In terms of its attractiveness to investors, Slovenia remains a mid-tier pharmaceutical industry within Emerging Europe. While not immune from economic factors and government austerity drives, ...

  • Industries : Drug and Medication
  • Countries : Slovenia
Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • May 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Our view that Slovenia’s drug industry is one of the most stable in the region remains in place despite the fact that - at the start of 2012 - the government ...

  • Industries : Drug and Medication
  • Countries : Slovenia
Vaccines - Global Markets Package

Vaccines - Global Markets Package

  • $ 24 060
  • Industry report
  • May 2013
  • by Global Research & Data Services

This industry data report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different countries around the world. The reports provide essential market ...

  • Industries : Drug and Medication
  • Countries : World, Europe, Asia, South America, Czech Republic, South Korea, Philippines, Africa, Australia, Argentina, United States, United Kingdom, Netherlands, Macedonia, Lithuania, Sri Lanka, Singapore, Kazakhstan, Indonesia, Bangladesh, Azerbaijan, South Africa, Uruguay, Ecuador, Chile, Colombia, Bolivia, Panama, Mexico, Canada, Ukraine, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Russian Federation, Romania, Portugal, Poland, Norway, Moldova, Republic Of, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Bulgaria, Belgium, Austria, Thailand, Pakistan, Nepal, Mongolia, Malaysia, Lebanon, Jordan, Japan, India, China, Georgia, Armenia, Sudan, Senegal, Nigeria, Morocco, Ghana, Ethiopia, Egypt, Kyrgyz Republic (kyrgyzstan), North America, Peru, Oman, Iran
Vaccine Market in Slovenia

Vaccine Market in Slovenia

  • $ 652
  • Industry report
  • May 2013
  • by Global Research & Data Services

This industry data report offers a perspective on the actual market situation, trends and future outlook for vaccines in Slovenia. The report provides essential market data for decision-makers including: ...

  • Industries : Drug and Medication
  • Countries : Slovenia
The 2013-2018 World Outlook for At-Home Vaginal Antifungal Treatments

The 2013-2018 World Outlook for At-Home Vaginal Antifungal Treatments

  • $ 795
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the world outlook for at-home vaginal antifungal ...

  • Industries : Drug and Medication
  • Countries : World, Africa, Europe, South America, North America, Asia, South Korea, Guinea, Dominican Republic, Central African Republic, Dominica, Czech Republic, Bosnia and Herzegovina, Gambia, France, Philippines, Congo, Democratic Republic Of, Papua New Guinea, Venezuela, Argentina, Nicaragua, Guatemala, El Salvador, Costa Rica, Antigua and Barbuda, United Kingdom, Switzerland, San Marino, Netherlands, Luxembourg, Liechtenstein, Lithuania, Sri Lanka, Singapore, North Korea, Kazakhstan, Indonesia, Bangladesh, Swaziland, South Africa, Sierra Leone, Seychelles, Sao Tome and Principe, Mozambique, Mauritania, Mauritius, Madagascar, Equatorial Guinea, Cape Verde, Burkina Faso, Uruguay, Suriname, Paraguay, Guyana, Ecuador, Chile, Colombia, Bolivia, Brazil, Panama, Mexico, Honduras, Canada, Belize, Barbados, Ukraine, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Russian Federation, Romania, Portugal, Poland, Norway, Monaco, Moldova, Republic Of, Malta, Latvia, Italy, Ireland, Iceland, Hungary, Greece, Germany, Finland, Estonia, Denmark, Cyprus, Croatia, Bulgaria, Belarus, Belgium, Austria, Andorra, Albania, Vietnam, Thailand, Taiwan, Nepal, Mongolia, Maldives, Malaysia, Japan, India, China, Georgia, Cambodia, Brunei Darussalam, Bhutan, Zimbabwe, Zambia, Uganda, Tunisia, Tanzania, Somalia, Senegal, Rwanda, Nigeria, Namibia, Niger, Morocco, Malawi, Libyan Arab Jamahiriya, Liberia, Lesotho, Kenya, Gabon, Ghana, Ethiopia, Djibouti, Egypt, Comoros, Cameroon, Burundi, Botswana, Benin, Angola, Algeria
The 2013-2018 World Outlook for Anti-Infective Pharmaceutical Preparations Affecting Anthelminics

The 2013-2018 World Outlook for Anti-Infective Pharmaceutical Preparations Affecting Anthelminics

  • $ 795
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the world outlook for anti-infective pharmaceutical ...

  • Industries : Drug and Medication
  • Countries : World, Africa, Europe, South America, North America, Asia, South Korea, Guinea, Dominican Republic, Central African Republic, Dominica, Czech Republic, Bosnia and Herzegovina, Gambia, France, Philippines, Congo, Democratic Republic Of, Papua New Guinea, Venezuela, Argentina, Nicaragua, Guatemala, El Salvador, Costa Rica, Antigua and Barbuda, United Kingdom, Switzerland, San Marino, Netherlands, Luxembourg, Liechtenstein, Lithuania, Sri Lanka, Singapore, North Korea, Kazakhstan, Indonesia, Bangladesh, Swaziland, South Africa, Sierra Leone, Seychelles, Sao Tome and Principe, Mozambique, Mauritania, Mauritius, Madagascar, Equatorial Guinea, Cape Verde, Burkina Faso, Uruguay, Suriname, Paraguay, Guyana, Ecuador, Chile, Colombia, Bolivia, Brazil, Panama, Mexico, Honduras, Canada, Belize, Barbados, Ukraine, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Russian Federation, Romania, Portugal, Poland, Norway, Monaco, Moldova, Republic Of, Malta, Latvia, Italy, Ireland, Iceland, Hungary, Greece, Germany, Finland, Estonia, Denmark, Cyprus, Croatia, Bulgaria, Belarus, Belgium, Austria, Andorra, Albania, Vietnam, Thailand, Taiwan, Nepal, Mongolia, Maldives, Malaysia, Japan, India, China, Georgia, Cambodia, Brunei Darussalam, Bhutan, Zimbabwe, Zambia, Uganda, Tunisia, Tanzania, Somalia, Senegal, Rwanda, Nigeria, Namibia, Niger, Morocco, Malawi, Libyan Arab Jamahiriya, Liberia, Lesotho, Kenya, Gabon, Ghana, Ethiopia, Djibouti, Egypt, Comoros, Cameroon, Burundi, Botswana, Benin, Angola, Algeria
The 2013-2018 World Outlook for Antispasmodic and Anticholinergic H2 Blocking Agents

The 2013-2018 World Outlook for Antispasmodic and Anticholinergic H2 Blocking Agents

  • $ 795
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the world outlook for antispasmodic and anticholinergic ...

  • Industries : Drug and Medication
  • Countries : World, Africa, Europe, South America, North America, Asia, South Korea, Guinea, Dominican Republic, Central African Republic, Dominica, Czech Republic, Bosnia and Herzegovina, Gambia, France, Philippines, Congo, Democratic Republic Of, Papua New Guinea, Venezuela, Argentina, Nicaragua, Guatemala, El Salvador, Costa Rica, Antigua and Barbuda, United Kingdom, Switzerland, San Marino, Netherlands, Luxembourg, Liechtenstein, Lithuania, Sri Lanka, Singapore, North Korea, Kazakhstan, Indonesia, Bangladesh, Swaziland, South Africa, Sierra Leone, Seychelles, Sao Tome and Principe, Mozambique, Mauritania, Mauritius, Madagascar, Equatorial Guinea, Cape Verde, Burkina Faso, Uruguay, Suriname, Paraguay, Guyana, Ecuador, Chile, Colombia, Bolivia, Brazil, Panama, Mexico, Honduras, Canada, Belize, Barbados, Ukraine, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Russian Federation, Romania, Portugal, Poland, Norway, Monaco, Moldova, Republic Of, Malta, Latvia, Italy, Ireland, Iceland, Hungary, Greece, Germany, Finland, Estonia, Denmark, Cyprus, Croatia, Bulgaria, Belarus, Belgium, Austria, Andorra, Albania, Vietnam, Thailand, Taiwan, Nepal, Mongolia, Maldives, Malaysia, Japan, India, China, Georgia, Cambodia, Brunei Darussalam, Bhutan, Zimbabwe, Zambia, Uganda, Tunisia, Tanzania, Somalia, Senegal, Rwanda, Nigeria, Namibia, Niger, Morocco, Malawi, Libyan Arab Jamahiriya, Liberia, Lesotho, Kenya, Gabon, Ghana, Ethiopia, Djibouti, Egypt, Comoros, Cameroon, Burundi, Botswana, Benin, Angola, Algeria
The 2013-2018 World Outlook for Cold Sore Medicines

The 2013-2018 World Outlook for Cold Sore Medicines

  • $ 795
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the world outlook for cold sore medicines across ...

  • Industries : Drug and Medication
  • Countries : World, Africa, Europe, South America, North America, Asia, South Korea, Guinea, Dominican Republic, Central African Republic, Dominica, Czech Republic, Bosnia and Herzegovina, Gambia, France, Philippines, Congo, Democratic Republic Of, Papua New Guinea, Venezuela, Argentina, Nicaragua, Guatemala, El Salvador, Costa Rica, Antigua and Barbuda, United Kingdom, Switzerland, San Marino, Netherlands, Luxembourg, Liechtenstein, Lithuania, Sri Lanka, Singapore, North Korea, Kazakhstan, Indonesia, Bangladesh, Swaziland, South Africa, Sierra Leone, Seychelles, Sao Tome and Principe, Mozambique, Mauritania, Mauritius, Madagascar, Equatorial Guinea, Cape Verde, Burkina Faso, Uruguay, Suriname, Paraguay, Guyana, Ecuador, Chile, Colombia, Bolivia, Brazil, Panama, Mexico, Honduras, Canada, Belize, Barbados, Ukraine, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Russian Federation, Romania, Portugal, Poland, Norway, Monaco, Moldova, Republic Of, Malta, Latvia, Italy, Ireland, Iceland, Hungary, Greece, Germany, Finland, Estonia, Denmark, Cyprus, Croatia, Bulgaria, Belarus, Belgium, Austria, Andorra, Albania, Vietnam, Thailand, Taiwan, Nepal, Mongolia, Maldives, Malaysia, Japan, India, China, Georgia, Cambodia, Brunei Darussalam, Bhutan, Zimbabwe, Zambia, Uganda, Tunisia, Tanzania, Somalia, Senegal, Rwanda, Nigeria, Namibia, Niger, Morocco, Malawi, Libyan Arab Jamahiriya, Liberia, Lesotho, Kenya, Gabon, Ghana, Ethiopia, Djibouti, Egypt, Comoros, Cameroon, Burundi, Botswana, Benin, Angola, Algeria
The 2013-2018 World Outlook for Cough, Cold, and Allergy Remedies

The 2013-2018 World Outlook for Cough, Cold, and Allergy Remedies

  • $ 795
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the world outlook for cough, cold, and allergy ...

  • Industries : Drug and Medication
  • Countries : World, Africa, Europe, South America, North America, Asia, South Korea, Guinea, Dominican Republic, Central African Republic, Dominica, Czech Republic, Bosnia and Herzegovina, Gambia, France, Philippines, Congo, Democratic Republic Of, Papua New Guinea, Venezuela, Argentina, Nicaragua, Guatemala, El Salvador, Costa Rica, Antigua and Barbuda, United Kingdom, Switzerland, San Marino, Netherlands, Luxembourg, Liechtenstein, Lithuania, Sri Lanka, Singapore, North Korea, Kazakhstan, Indonesia, Bangladesh, Swaziland, South Africa, Sierra Leone, Seychelles, Sao Tome and Principe, Mozambique, Mauritania, Mauritius, Madagascar, Equatorial Guinea, Cape Verde, Burkina Faso, Uruguay, Suriname, Paraguay, Guyana, Ecuador, Chile, Colombia, Bolivia, Brazil, Panama, Mexico, Honduras, Canada, Belize, Barbados, Ukraine, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Russian Federation, Romania, Portugal, Poland, Norway, Monaco, Moldova, Republic Of, Malta, Latvia, Italy, Ireland, Iceland, Hungary, Greece, Germany, Finland, Estonia, Denmark, Cyprus, Croatia, Bulgaria, Belarus, Belgium, Austria, Andorra, Albania, Vietnam, Thailand, Taiwan, Nepal, Mongolia, Maldives, Malaysia, Japan, India, China, Georgia, Cambodia, Brunei Darussalam, Bhutan, Zimbabwe, Zambia, Uganda, Tunisia, Tanzania, Somalia, Senegal, Rwanda, Nigeria, Namibia, Niger, Morocco, Malawi, Libyan Arab Jamahiriya, Liberia, Lesotho, Kenya, Gabon, Ghana, Ethiopia, Djibouti, Egypt, Comoros, Cameroon, Burundi, Botswana, Benin, Angola, Algeria
The 2013-2018 World Outlook for Head and Body Antiparasitic and Lice Treatments

The 2013-2018 World Outlook for Head and Body Antiparasitic and Lice Treatments

  • $ 795
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the world outlook for head and body antiparasitic ...

  • Industries : Drug and Medication
  • Countries : World, Africa, Europe, South America, North America, Asia, South Korea, Guinea, Dominican Republic, Central African Republic, Dominica, Czech Republic, Bosnia and Herzegovina, Gambia, France, Philippines, Congo, Democratic Republic Of, Papua New Guinea, Venezuela, Argentina, Nicaragua, Guatemala, El Salvador, Costa Rica, Antigua and Barbuda, United Kingdom, Switzerland, San Marino, Netherlands, Luxembourg, Liechtenstein, Lithuania, Sri Lanka, Singapore, North Korea, Kazakhstan, Indonesia, Bangladesh, Swaziland, South Africa, Sierra Leone, Seychelles, Sao Tome and Principe, Mozambique, Mauritania, Mauritius, Madagascar, Equatorial Guinea, Cape Verde, Burkina Faso, Uruguay, Suriname, Paraguay, Guyana, Ecuador, Chile, Colombia, Bolivia, Brazil, Panama, Mexico, Honduras, Canada, Belize, Barbados, Ukraine, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Russian Federation, Romania, Portugal, Poland, Norway, Monaco, Moldova, Republic Of, Malta, Latvia, Italy, Ireland, Iceland, Hungary, Greece, Germany, Finland, Estonia, Denmark, Cyprus, Croatia, Bulgaria, Belarus, Belgium, Austria, Andorra, Albania, Vietnam, Thailand, Taiwan, Nepal, Mongolia, Maldives, Malaysia, Japan, India, China, Georgia, Cambodia, Brunei Darussalam, Bhutan, Zimbabwe, Zambia, Uganda, Tunisia, Tanzania, Somalia, Senegal, Rwanda, Nigeria, Namibia, Niger, Morocco, Malawi, Libyan Arab Jamahiriya, Liberia, Lesotho, Kenya, Gabon, Ghana, Ethiopia, Djibouti, Egypt, Comoros, Cameroon, Burundi, Botswana, Benin, Angola, Algeria
The 2013-2018 World Outlook for Prescription Non-Barbituate Anxiolytic and Hypnotic Sedatives

The 2013-2018 World Outlook for Prescription Non-Barbituate Anxiolytic and Hypnotic Sedatives

  • $ 795
  • Industry report
  • January 2013
  • by ICON Group

This report does not cover the individual items, but rather the aggregate level of demand across all items within the category. This econometric study covers the world outlook for prescription non-barbituate ...

  • Industries : Drug and Medication
  • Countries : World, Africa, Europe, South America, North America, Asia, South Korea, Guinea, Dominican Republic, Central African Republic, Dominica, Czech Republic, Bosnia and Herzegovina, Gambia, France, Philippines, Congo, Democratic Republic Of, Papua New Guinea, Venezuela, Argentina, Nicaragua, Guatemala, El Salvador, Costa Rica, Antigua and Barbuda, United Kingdom, Switzerland, San Marino, Netherlands, Luxembourg, Liechtenstein, Lithuania, Sri Lanka, Singapore, North Korea, Kazakhstan, Indonesia, Bangladesh, Swaziland, South Africa, Sierra Leone, Seychelles, Sao Tome and Principe, Mozambique, Mauritania, Mauritius, Madagascar, Equatorial Guinea, Cape Verde, Burkina Faso, Uruguay, Suriname, Paraguay, Guyana, Ecuador, Chile, Colombia, Bolivia, Brazil, Panama, Mexico, Honduras, Canada, Belize, Barbados, Ukraine, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Russian Federation, Romania, Portugal, Poland, Norway, Monaco, Moldova, Republic Of, Malta, Latvia, Italy, Ireland, Iceland, Hungary, Greece, Germany, Finland, Estonia, Denmark, Cyprus, Croatia, Bulgaria, Belarus, Belgium, Austria, Andorra, Albania, Vietnam, Thailand, Taiwan, Nepal, Mongolia, Maldives, Malaysia, Japan, India, China, Georgia, Cambodia, Brunei Darussalam, Bhutan, Zimbabwe, Zambia, Uganda, Tunisia, Tanzania, Somalia, Senegal, Rwanda, Nigeria, Namibia, Niger, Morocco, Malawi, Libyan Arab Jamahiriya, Liberia, Lesotho, Kenya, Gabon, Ghana, Ethiopia, Djibouti, Egypt, Comoros, Cameroon, Burundi, Botswana, Benin, Angola, Algeria


16 reports

Download Unlimited Documents from Trusted Public Sources

Drug And Medication Markets in Europe - Forecast

  • January 2014
    4 pages
  • Drug And Medica...  

  • Europe  

    Slovenia  

    Russian Federat...  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.